What is the Novelix Pharmaceuticals Ltd share price today?

The share price of BSE:NOVELIX-XT on 07 Sep 2026 (as of 11:01:44 IST) is ₹78.20.

What is the BSE:NOVELIX-XT 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the BSE:NOVELIX-XT 52 week high low range shows a high of ₹92.00 and a low of ₹38.00.

What is the Novelix Pharmaceuticals Ltd market cap?

As on 07 Sep 2026, Novelix Pharmaceuticals Ltd market cap is ₹217.94 Cr.

What is the shareholding pattern of Novelix Pharmaceuticals Ltd Stock?

The shareholding pattern of Novelix Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 50.57% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 49.43% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Novelix Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Novelix Pharmaceuticals Ltd is 60.04, and the Price-to-Book (PB) ratio is 1.51, as on 07 Sep 2026.

Novelix Pharmaceuticals Share Price

72.01-0.51 (-0.70%)

+76.11% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-0.70%

1 Week

-7.99%

1 Month

-10.99%

3 Month

-9.99%

6 Month

+29.10%

YTD

+15.00%

1 Year

+76.11%

5 Year

10 Year

Max

+170.61%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

72.01

72.00

71.60

63.19

49.01

38.00

High

73.00

82.00

83.50

83.99

92.00

About

Trimurthi Limited is a Public Limited Company having Registered Office situated at Hyderabad, Telangana. The company is into the business of Trading of Pharmaceuticals and related products and is into Read more

Trading

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

ADANIENT-ANSE

AEGISLOG-ANSE

CPPLUS-ANSE

PREMIERENE-ANSE

REDINGTON-ANSE

HONASA-ANSE

LLOYDSENT-ANSE

CELLO-ANSE

JSLL-ANSE

SREEL-TNSE

NOVELIX-XNSE

LTP

1W Low

1W High

Market cap (₹)

2920-79.1 (-2.64%)

2900

3025

4,04,763Cr

1373.5-43.75 (-3.09%)

1347.50

1528

49,337Cr

3798.85+447 (13.34%)

3344.30

3875.70

45,264Cr

898-5 (-0.55%)

885.10

919.30

41,326Cr

406.45+6.75 (1.69%)

390.60

419.55

31,353Cr

475.35-4.25 (-0.89%)

466

491.75

15,804Cr

75.52+6.73 (9.78%)

67.25

77.10

11,326Cr

340.15+17.6 (5.46%)

314.90

344.10

7,311Cr

511.55+1.9 (0.37%)

505

530.50

6,517Cr

299.95+13.15 (4.59%)

266.60

305

673Cr

70.51-7.75 (-9.90%)

66.21

206Cr

Novelix Pharmaceuticals Share Price

72.01-0.51 (-0.70%)

+76.11% past 1 Year

Financial overview

Compounded Sales Growth

10 years36%

5 years97%

3 years232%

Last year627%

Compounded Profit Growth

10 years16%

5 years7%

3 years-

Last year712%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year77%

Return on Equity

10 years-4%

5 years-10%

3 years0%

Last year1%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
36%	97%	232%	627%
16%	7%	-	712%
-	-	-	77%
-4%	-10%	0%	1%

Peer Comparison

Symbol

ADANIENT-A

AEGISLOG-A

CPPLUS-A

PREMIERENE-A

REDINGTON-A

HONASA-A

LLOYDSENT-A

CELLO-A

JSLL-A

SREEL-T

NOVELIX-X

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
2,946.2	₹404763 Cr	54.37	-8.91	105.06	₹9339 Cr
1,375.8	₹49337 Cr	39.43	13.8	41.65	₹898 Cr
3,818	₹45264 Cr	94.84	12.07	45.29	₹368 Cr
905.9	₹41326 Cr	24.82	10.2	45.28	₹1510 Cr
399.45	₹31353 Cr	18.43	6.22	24.36	₹1490 Cr
483.25	₹15804 Cr	63.5	2.77	8.99	₹200 Cr
76.39	₹11326 Cr	100.86	0.38	0.91	₹283 Cr
335.55	₹7311 Cr	23.37	3.32	17.46	₹332 Cr
517.6	₹6517 Cr	27.56	5.31	23.32	₹222 Cr
305	₹673 Cr	20.51	3.02	14.74	₹29 Cr
72.01	₹206 Cr	56.88	0.49	1.33	₹3 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016	Sep 2016	Jun 2016	Mar 2016	Dec 2015	Sep 2015	Jun 2015	Mar 2015	Dec 2014	Sep 2014	Jun 2014	Mar 2014	Dec 2013	Sep 2013	Jun 2013	Mar 2013	Dec 2012	Sep 2012
₹37 Cr	₹25 Cr	₹48 Cr	₹36 Cr	₹22 Cr	₹21 Cr	₹5 Cr	₹4 Cr	₹60 L	₹84 L	₹50 L	₹93 L	₹2 Cr	₹87 L	₹43 L	₹5 L	₹7 L	₹7 L	₹9 L	₹21 L	₹47 L	₹32 L	₹12 L	₹30 L	₹24 L	₹51 L	₹18 L	₹15 L	₹32 L	₹49 L	₹99 L	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹27 L	₹30 L	₹12 L	₹80 L	₹54 L	₹2 Cr	₹27 L	₹24 L	₹21 L	₹21 L	₹31 L	₹31 L	₹26 L	₹58 L	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr
₹10,000	₹0	₹0	₹3 L	₹0	₹0	₹10,000	-₹8 L	₹10 L	₹13 L	₹9 L	₹5 L	₹5 L	₹23 L	₹18 L	₹4 L	₹6 L	₹9 L	₹7 L	₹30 L	₹10 L	₹5 L	₹10 L	₹6 L	₹11 L	₹10 L	₹12 L	₹8 L	₹4 L	₹11 L	-₹30,000	₹2 L	₹90,000	-₹90,000	₹10,000	₹10,000	₹23 L	₹18 L	₹32 L	₹0	₹10 L	-₹4 L	₹3 L	₹4 L	₹5 L	-₹21 L	₹0	₹0	₹0	₹0	₹0	₹29 L	₹21 L	₹60,000	₹24 L	₹20 L
₹37 Cr	₹25 Cr	₹48 Cr	₹36 Cr	₹22 Cr	₹21 Cr	₹5 Cr	₹4 Cr	₹70 L	₹97 L	₹58 L	₹98 L	₹2 Cr	₹1 Cr	₹61 L	₹9 L	₹12 L	₹16 L	₹16 L	₹50 L	₹57 L	₹38 L	₹22 L	₹37 L	₹35 L	₹61 L	₹30 L	₹23 L	₹36 L	₹60 L	₹99 L	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹27 L	₹53 L	₹30 L	₹1 Cr	₹54 L	₹2 Cr	₹24 L	₹27 L	₹25 L	₹26 L	₹10 L	₹31 L	₹26 L	₹58 L	₹2 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr
₹36 Cr	₹24 Cr	₹47 Cr	₹36 Cr	₹22 Cr	₹21 Cr	₹5 Cr	₹4 Cr	₹1 Cr	₹69 L	₹58 L	₹1 Cr	₹2 Cr	₹1 Cr	₹55 L	₹17 L	₹18 L	₹2 Cr	₹24 L	₹23 L	₹70 L	₹3 Cr	₹27 L	₹43 L	₹42 L	₹42 L	₹32 L	₹35 L	₹32 L	₹46 L	₹98 L	₹1 Cr	₹1 Cr	₹1 Cr	₹98 L	₹15 L	₹38 L	₹31 L	₹88 L	₹53 L	₹2 Cr	₹31 L	₹21 L	₹17 L	₹19 L	₹42 L	₹14 L	₹12 L	₹48 L	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr
₹1 Cr	₹1 Cr	₹1 Cr	₹73 L	₹18 L	₹23 L	₹13 L	₹14 L	-₹34 L	₹28 L	₹2 L	-₹6 L	-₹14 L	₹3 L	₹9 L	-₹7 L	-₹5 L	-₹2 Cr	-₹5 L	₹28 L	-₹11 L	-₹3 Cr	-₹3 L	-₹4 L	-₹4 L	₹21 L	₹80,000	-₹10 L	₹7 L	₹18 L	₹3 L	₹7 L	₹4 L	-₹1 L	₹11 L	₹16 L	₹19 L	₹3 L	₹27 L	₹4 L	-₹3 L	₹50,000	₹17 L	₹14 L	₹15 L	-₹15 L	₹24 L	₹22 L	₹18 L	₹10 L	₹22 L	₹31 L	₹27 L	₹10 L	₹27 L	₹25 L
₹12 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹4 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹10,000	₹10,000	₹20,000	₹0	₹10,000	₹20,000	₹20,000	₹20,000	₹70,000	₹0	₹0
₹1 Cr	₹1 Cr	₹1 Cr	₹72 L	₹17 L	₹21 L	₹13 L	₹13 L	-₹35 L	₹28 L	-₹4 L	-₹7 L	-₹15 L	₹1 L	₹6 L	-₹8 L	-₹6 L	-₹2 Cr	-₹8 L	₹27 L	-₹13 L	-₹3 Cr	-₹5 L	-₹7 L	-₹7 L	₹20 L	-₹1 L	-₹12 L	₹4 L	₹14 L	₹40,000	₹4 L	₹90,000	-₹6 L	₹7 L	₹12 L	₹15 L	-₹90,000	₹23 L	₹1 L	-₹6 L	-₹8 L	₹6 L	₹8 L	₹7 L	-₹32 L	₹17 L	₹14 L	₹10 L	₹3 L	₹14 L	₹24 L	₹20 L	₹2 L	₹20 L	₹19 L
₹1 Cr	₹91 L	₹1 Cr	₹53 L	₹11 L	₹18 L	₹15 L	₹13 L	-₹35 L	₹28 L	-₹3 L	-₹7 L	-₹17 L	₹1 L	₹7 L	-₹9 L	-₹6 L	-₹2 Cr	-₹1 L	₹21 L	-₹13 L	-₹3 Cr	-₹5 L	-₹6 L	-₹6 L	₹19 L	-₹1 L	-₹11 L	₹3 L	₹11 L	₹5 L	₹6 L	₹3 L	-₹8 L	₹5 L	₹10 L	₹11 L	₹60,000	₹17 L	₹1 L	-₹6 L	-₹6 L	₹1 L	₹6 L	₹5 L	-₹26 L	₹12 L	₹10 L	₹7 L	₹4 L	₹10 L	₹15 L	₹14 L	₹2 L	₹11 L	₹14 L

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Deferred Tax Assets / Liabilities

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹10 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹7 Cr
₹8 Cr	-₹75 L	-₹90 L	-₹86 L	₹70 L	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹87 L	₹42 L	₹33 L
₹8 Cr	-₹75 L	-₹90 L	-₹86 L	₹70 L	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹87 L	₹42 L	₹33 L
₹18 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹9 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹11 Cr	₹11 Cr	₹11 Cr	₹11 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹7 Cr	₹7 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹1 L	₹4 L	₹0	₹8 L	₹23 L	₹20 L	₹0
-₹4 L	-₹5 L	-₹6 L	-₹7 L	-₹6 L	-₹6 L	-₹6 L	₹4 L	₹2 L	₹2 L	₹8 L	₹12 L	₹14 L	₹16 L	₹18 L	₹21 L	₹19 L	₹16 L
-₹4 L	-₹5 L	-₹6 L	-₹7 L	-₹6 L	-₹6 L	-₹6 L	₹4 L	₹2 L	₹2 L	₹8 L	₹13 L	₹18 L	₹16 L	₹25 L	₹43 L	₹39 L	₹16 L
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹9 Cr	₹30,040	₹5 L	₹0	₹1 L	₹66,894	₹10 L	₹31 L	₹0	₹0	₹0	₹5 L	₹2 L	₹2 Cr	₹8 L	₹9 L	₹30 L	₹35 L
₹0	₹71,320	₹78,450	₹81,500	₹98,000	₹1 L	₹4 L	₹7 L	₹7 L	₹8 L	₹7 L	₹11 L	₹11 L	₹3 Cr	₹15 L	₹10 L	₹3 L	₹50,750
₹37 L	₹0	₹0	₹0	₹0	₹63,870	₹4 L	₹8 L	₹5 L	₹10 L	₹10 L	₹21 L	₹20 L	₹39 L	₹48 L	₹44 L	₹36 L	₹10 L
₹10 Cr	₹1 L	₹6 L	₹81,500	₹2 L	₹3 L	₹18 L	₹47 L	₹13 L	₹17 L	₹18 L	₹37 L	₹33 L	₹5 Cr	₹71 L	₹63 L	₹69 L	₹45 L
₹27 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹9 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹13 Cr	₹9 Cr	₹9 Cr	₹8 Cr	₹8 Cr
₹0	₹0	₹0	₹0	₹3 L	₹3 L	₹3 L	₹3 L	₹3 L	₹3 L	₹0	₹0	₹0	₹0	₹93,461	₹0	₹3 L	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹4 L	₹7 L	₹8 L	₹15 L	₹23 L	₹20 L	₹0
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr
₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹97 L	₹73 L	₹51 L
₹19 L	₹12 L	₹17 L	₹23 L	₹22 L	₹31 L	₹37 L	₹61 L	₹59 L	₹55 L	₹75 L	₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹8 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹4 L	₹3 Cr	₹3 Cr	₹59 L	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹32 L	₹2 L	₹51 L	₹52 L	₹81 L	₹25 L	₹32 L
₹4 L	₹3 Cr	₹3 Cr	₹59 L	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹32 L	₹2 L	₹51 L	₹52 L	₹81 L	₹25 L	₹32 L
₹0	₹0	₹0	₹0	₹20 L	₹20 L	₹21 L	₹21 L	₹21 L	₹23 L	₹21 L	₹21 L	₹34 L	₹34 L	₹23 L	₹0	₹0	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹9 L	₹0	₹0	₹0
₹23 L	₹3 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹2 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹2 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹84 L	₹1 Cr	₹82 L	₹53 L	₹25 L	₹8 L	₹10 L	₹11 L	₹22 L	₹0	₹0	₹32 L	₹33 L	₹60 L	₹1 Cr	₹80 L	₹55 L	₹1 Cr
₹18 Cr	₹1 L	₹19 L	₹10 L	₹9 L	₹8 L	₹2 Cr	₹1 Cr	₹40 L	₹73,301	₹12 L	₹85 L	₹82 L	₹5 Cr	₹95 L	₹1 Cr	₹94 L	₹80 L
₹68 L	₹12 L	₹27 L	₹3 Cr	₹2 Cr	₹95 L	₹16 L	₹15 L	₹34 L	₹44 L	₹17 L	₹87 L	₹37 L	₹36 L	₹33 L	₹17 L	₹97 L	₹1 Cr
₹2 L	₹7 L	₹5 L	₹30 L	₹24 L	₹2 Cr	₹13 L	₹6 L	₹3 L	₹3 L	₹1 L	₹0	₹8 L	₹0	₹5 L	₹1,549	₹1,549	₹90,802
₹7 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹5 Cr	₹6 Cr	₹7 Cr	₹8 Cr	₹7 Cr	₹9 Cr	₹8 Cr	₹8 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹2 Cr
₹27 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹8 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹10 Cr	₹10 Cr	₹11 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr
₹17 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹8 Cr	₹9 Cr	₹8 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹10 Cr	₹10 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹6 Cr	₹5 Cr
₹27 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹9 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹13 Cr	₹9 Cr	₹9 Cr	₹8 Cr	₹8 Cr
₹18	₹9	₹9	₹9	₹11	₹15	₹15	₹15	₹14	₹14	₹14	₹14	₹14	₹12	₹12	₹1	₹11	₹10
₹18	₹9	₹9	₹9	₹11	₹15	₹15	₹15	₹14	₹14	₹14	₹14	₹14	₹12	₹12	₹11	₹11	₹10

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
₹12 L	₹2 L	-₹6 L	-₹2 Cr	-₹3 Cr	₹11 L	₹19 L	₹29 L	₹20 L	₹14 L	₹9 L	₹61 L	₹55 L	₹61 L	₹70 L	₹91 L	₹48 L	₹63 L
₹2 L	-₹27 L	-₹46 L	₹1 Cr	-₹24 L	-₹36 L	-₹7 L	₹22 L	₹24 L	₹26 L	-₹54 L	-₹61 L	-₹44 L	-₹40 L	-₹36 L	-₹28 L	-₹28 L	-₹34 L
-₹14 Cr	-₹10 L	-₹2 Cr	₹1 Cr	₹4 Cr	₹2 Cr	-₹55 L	₹66 L	-₹1 Cr	₹2 Cr	₹12 L	₹25 L	-₹3 Cr	-₹37 L	-₹44 L	-₹77 L	-₹60 L	-₹45 L
-₹14 Cr	-₹34 L	-₹2 Cr	₹59 L	₹58 L	₹1 Cr	-₹43 L	₹1 Cr	-₹1 Cr	₹2 Cr	-₹33 L	₹25 L	-₹3 Cr	-₹16 L	-₹11 L	-₹14 L	-₹40 L	-₹15 L
-₹14 Cr	-₹34 L	-₹2 Cr	₹59 L	₹58 L	₹1 Cr	-₹44 L	₹1 Cr	-₹1 Cr	₹2 Cr	-₹43 L	₹3 L	-₹3 Cr	-₹35 L	-₹59 L	-₹58 L	-₹79 L	-₹30 L
₹3 Cr	₹19 L	₹8 L	₹28 L	₹21 L	-₹42 L	₹45 L	-₹1 Cr	₹97 L	-₹2 Cr	-₹25 L	₹50 L	₹1 Cr	₹65 L	₹83 L	-₹24 L	₹44 L	₹39 L
₹11 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	-₹1 L	-₹3 L	₹2 Cr	-₹28 L	-₹7 L	₹2 L	₹20 L	₹75 L
₹56 L	-₹16 L	-₹2 Cr	₹87 L	₹78 L	₹79 L	₹72,000	-₹19 L	-₹10 L	₹27 L	-₹69 L	₹50 L	₹1 L	₹2 L	₹17 L	-₹80 L	-₹14 L	₹84 L
₹12 L	₹27 L	₹3 Cr	₹2 Cr	₹95 L	₹16 L	₹15 L	₹34 L	₹44 L	₹17 L	₹87 L	₹37 L	₹36 L	₹33 L	₹17 L	₹97 L	₹1 Cr	₹28 L
₹68 L	₹12 L	₹27 L	₹3 Cr	₹2 Cr	₹95 L	₹16 L	₹15 L	₹34 L	₹44 L	₹17 L	₹87 L	₹37 L	₹36 L	₹34 L	₹17 L	₹97 L	₹1 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Novelix Pharmaceuticals Share Price

72.01-0.51 (-0.70%)

+76.11% past 1 Year

Shareholding summary

Promoters

50.57%

FII

DII

Others

49.43%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
50.57%	49.43%	51.98%	53.33%	52.75%	66.56%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
49.43%	50.57%	48.02%	46.67%	47.25%	33.44%

Bulk & block deals

Name

Medo Capital Services Private Limited

Indus Capital Private Limited

Bekae Properties Private Limited

Kiran Bhangadia

Arun Kumar Bhangadia

Shreevishwamurte Tradinvest Private Limited

Preeti Gagan Arora

Shreevishwamurte Tradinvest Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
03 Jul 2025	Sell	54.11 L	₹43.29	1.25 L	Bulk	0.709622	BSE
12 Jan 2022	Purchase	4.88 L	₹8.55	57.13 K	Bulk	0.324343	BSE
12 Jan 2022	Sell	4.88 L	₹8.55	57.13 K	Bulk	0.324343	BSE
09 May 2014	Purchase	3.06 L	₹7.11	43 K	Bulk	0.24411	BSE
21 Feb 2014	Purchase	2.33 L	₹4.66	50 K	Bulk	0.283849	BSE
20 Feb 2014	Purchase	2.81 L	₹4.68	60 K	Bulk	0.340619	BSE
14 Feb 2014	Purchase	3.28 L	₹5.38	61.01 K	Bulk	0.346347	BSE
07 Feb 2014	Purchase	4.48 L	₹6.27	71.45 K	Bulk	0.405637	BSE
07 Feb 2014	Sell	4.56 L	₹6.38	71.45 K	Bulk	0.405637	BSE
31 Jan 2014	Purchase	4.85 L	₹7.30	66.45 K	Bulk	0.377224	BSE

Insider trading & SAST

Client name

Vupparapalli Chandrasekhar Reddy & Others

Srinidhi Fine-Chemicals Llp & Narahari Belide

Gattu Gnana Prakash & Others

Neha Gattu

Narhari Belide

Srinidhi Fine Chemicals Llp

Vupparapalli Chandrasekhar

Gattu Gnana Prakash & Others

Srindhi Fine Chemicals Llp & Others

Vupparapalli Reddy & Other

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
06 Aug 2026	Promoter	Acquisition	1.29	12.75	0	—	7.75 L	09 Jul 2026	Conv. of Warrants	36,30,733	SAST	29(2)	—
06 Aug 2026	Other	Acquisition	2.93	39.35	0	—	21 L	09 Jul 2026	Conv. of Warrants	1,12,02,000	SAST	29(2)	—
06 Aug 2026	Promoter	Acquisition	0.35	2.11	0	—	1 L	09 Jul 2026	Conv. of Warrants	6,00,000	SAST	29(2)	—
13 Jul 2026	Promoter Group	Acquisition	0.567698	0.35	20 L	₹20	1 L	09 Jul 2026	Allotment	1,00,000	Insider Trading	—	Equity
13 Jul 2026	Promoter Group	Acquisition	2.270792	4.21	80 L	₹20	4 L	09 Jul 2026	Allotment	12,00,000	Insider Trading	—	Equity
13 Jul 2026	Promoter	Acquisition	11.921658	35.13	4.20 Cr	₹20	21 L	09 Jul 2026	Allotment	1,00,02,000	Insider Trading	—	Equity
13 Jul 2026	Promoter	Acquisition	4.399659	10.21	1.55 Cr	₹20	7.75 L	09 Jul 2026	Allotment	29,05,733	Insider Trading	—	Equity
06 Jul 2026	Promoter	Acquisition	0.43	2.09	0	—	1.50 L	29 May 2026	Conv. of Warrants	5,00,000	SAST	29(2)	—
06 Jul 2026	Promoter	Acquisition	0.35	36.42	0	—	9.50 L	29 May 2026	Conv. of Warrants	87,02,000	SAST	29(2)	—
06 Jul 2026	Promoter	Acquisition	1.47	11.95	0	—	5.60 L	29 May 2026	Conv. of Warrants	28,55,733	SAST	29(2)	—

Novelix Pharmaceuticals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Novelix Pharmaceuticals Share Price

Novelix Pharmaceuticals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Novelix Pharmaceuticals Share Price

Novelix Pharmaceuticals Share Price

Oscillators

Moving averages

Novelix Pharmaceuticals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Novelix Pharmaceuticals Share Price

Corporate Actions

Company details

Novelix Pharmaceuticals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Novelix Pharmaceuticals Share Price

News

Novelix Pharmaceuticals jumps on entering into agreement with GMBU e.V., Halle

Novelix Pharmaceuticals informs about execution of agreement

Novelix Pharmaceuticals informs about updates

Novelix Pharmaceuticals informs about SAST updates

Novelix Pharmaceuticals informs about disclosure

Novelix Pharmaceuticals informs about disclosure

Novelix Pharmaceuticals informs about disclosure

Novelix Pharma reports Profit after tax of 91.40 Lakhs, in the March 2026 quarter

Novelix Pharmaceuticals informs about disclosure

Novelix Pharmaceuticals informs about disclosure

Novelix Pharmaceuticals informs about disclosure

Novelix Pharma reports Profit after tax of 1.01 Crores, in the December 2025 quarter

Novelix Pharma reports Profit after tax of 53.20 Lakhs, in the September 2025 quarter

Novelix Pharmaceuticals touches roof on signing technology transfer agreement with GMBU e.V.

Novelix Pharmaceuticals signs technology transfer agreement with GMBU e.V.

Novelix Pharma reports Profit after tax of 10.60 Lakhs, in the June 2025 quarter

Novelix Pharma - Quaterly Results

Novelix Pharma - Quaterly Results

Novelix Pharmaceuticals informs about board meeting

Novelix Pharma reports Profit after tax of 18.30 Lakhs, in the March 2025 quarter

Novelix Pharmaceuticals Ltd Share Price Today

Novelix Pharmaceuticals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator